131 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Pharma’s team has delivered innovative treatments to rare disease patients with high unmet medical needs. By joining forces and expertise we will be able … Global Rare Diseases
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
2023.
About Amryt
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
.
About AmrytAmryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments
6-K
EX-99.2
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio
6-K
EX-99.3
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
#.
About AmrytAmryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments
6-K
EX-99.4
lfcb1bd3ne
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.5
pqfs1e51jlopgorvyo
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.7
v4vt78d6hi9ij
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.6
hqfrh51h9jdxo5tseyv
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
taexiwj
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.4
qv335ej
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.2
6b7glah30zd
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
bfw3exo68hkb dyxpn
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.5
0f9xd8ya1
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
2uq8b5f87on9untn
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.4
5lyq0zgshcok9xafljsd
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.3
nag dlphvruz
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
47moh s9l3wnv2
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
b1a9fnz
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
EX-99.1
ppyq0advm0aw087k
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am